Lazard Capital Downgrades MAKO Surgical (MAKO) to Hold
MAKO Hot Sheet
Rating Summary:3 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 2 | New: 2
Lazard Capital downgrades MAKO Surgical (Nasdaq: MAKO) from Buy to Hold.
To see more analyst ratings on MAKO Click Here.
MAKO Surgical Corp., a medical device company, provides advanced robotic solution and orthopedic implants for minimally invasive orthopedic knee procedures.
To see more analyst ratings on MAKO Click Here.
MAKO Surgical Corp., a medical device company, provides advanced robotic solution and orthopedic implants for minimally invasive orthopedic knee procedures.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Barclays on U.S. REITs: Best Ideas List: Adding HPP; Removing ARE
- Wells Fargo Upgrades Watson Pharmaceuticals (WPI) to Outperform; Actavis Acquisition Adds Growth Prospects
Create E-mail Alert Related Categories
DowngradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
